1258 related articles for article (PubMed ID: 29551272)
1. Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors.
Konermann S; Lotfy P; Brideau NJ; Oki J; Shokhirev MN; Hsu PD
Cell; 2018 Apr; 173(3):665-676.e14. PubMed ID: 29551272
[TBL] [Abstract][Full Text] [Related]
2. Functional Features and Current Applications of the RNA-Targeting Type VI CRISPR-Cas Systems.
Perčulija V; Lin J; Zhang B; Ouyang S
Adv Sci (Weinh); 2021 Jul; 8(13):2004685. PubMed ID: 34254038
[TBL] [Abstract][Full Text] [Related]
3. Efficient RNA Virus Targeting via CRISPR/CasRx in Fish.
Wang Q; Liu Y; Han C; Yang M; Huang F; Duan X; Wang S; Yu Y; Liu J; Yang H; Lu D; Zhao H; Zhang Y; Qin Q
J Virol; 2021 Sep; 95(19):e0046121. PubMed ID: 34287045
[TBL] [Abstract][Full Text] [Related]
4. Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR-Cas Systems.
O'Connell MR
J Mol Biol; 2019 Jan; 431(1):66-87. PubMed ID: 29940185
[TBL] [Abstract][Full Text] [Related]
5. Cas13d Is a Compact RNA-Targeting Type VI CRISPR Effector Positively Modulated by a WYL-Domain-Containing Accessory Protein.
Yan WX; Chong S; Zhang H; Makarova KS; Koonin EV; Cheng DR; Scott DA
Mol Cell; 2018 Apr; 70(2):327-339.e5. PubMed ID: 29551514
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitous and Tissue-specific RNA Targeting in Drosophila Melanogaster using CRISPR/CasRx.
Sun R; Brogan D; Buchman A; Yang T; Akbari OS
J Vis Exp; 2021 Feb; (168):. PubMed ID: 33616113
[TBL] [Abstract][Full Text] [Related]
7. Cas13b Is a Type VI-B CRISPR-Associated RNA-Guided RNase Differentially Regulated by Accessory Proteins Csx27 and Csx28.
Smargon AA; Cox DBT; Pyzocha NK; Zheng K; Slaymaker IM; Gootenberg JS; Abudayyeh OA; Essletzbichler P; Shmakov S; Makarova KS; Koonin EV; Zhang F
Mol Cell; 2017 Feb; 65(4):618-630.e7. PubMed ID: 28065598
[TBL] [Abstract][Full Text] [Related]
8. Structure and engineering of the minimal type VI CRISPR-Cas13bt3.
Nakagawa R; Kannan S; Altae-Tran H; Takeda SN; Tomita A; Hirano H; Kusakizako T; Nishizawa T; Yamashita K; Zhang F; Nishimasu H; Nureki O
Mol Cell; 2022 Sep; 82(17):3178-3192.e5. PubMed ID: 36027912
[TBL] [Abstract][Full Text] [Related]
9. Programmable RNA Targeting Using CasRx in Flies.
Buchman AB; Brogan DJ; Sun R; Yang T; Hsu PD; Akbari OS
CRISPR J; 2020 Jun; 3(3):164-176. PubMed ID: 32584145
[TBL] [Abstract][Full Text] [Related]
10. CRISPR-Cas13d mediates robust RNA virus interference in plants.
Mahas A; Aman R; Mahfouz M
Genome Biol; 2019 Dec; 20(1):263. PubMed ID: 31791381
[TBL] [Abstract][Full Text] [Related]
11. CASowary: CRISPR-Cas13 guide RNA predictor for transcript depletion.
Krohannon A; Srivastava M; Rauch S; Srivastava R; Dickinson BC; Janga SC
BMC Genomics; 2022 Mar; 23(1):172. PubMed ID: 35236300
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas13d-Mediated Microbial RNA Knockdown.
Zhang K; Zhang Z; Kang J; Chen J; Liu J; Gao N; Fan L; Zheng P; Wang Y; Sun J
Front Bioeng Biotechnol; 2020; 8():856. PubMed ID: 32850723
[TBL] [Abstract][Full Text] [Related]
13. Cas13d: A New Molecular Scissor for Transcriptome Engineering.
Gupta R; Ghosh A; Chakravarti R; Singh R; Ravichandiran V; Swarnakar S; Ghosh D
Front Cell Dev Biol; 2022; 10():866800. PubMed ID: 35433685
[TBL] [Abstract][Full Text] [Related]
14. RNA-targeting CRISPR systems from metagenomic discovery to transcriptomic engineering.
Smargon AA; Shi YJ; Yeo GW
Nat Cell Biol; 2020 Feb; 22(2):143-150. PubMed ID: 32015437
[TBL] [Abstract][Full Text] [Related]
15. Structural Basis for the RNA-Guided Ribonuclease Activity of CRISPR-Cas13d.
Zhang C; Konermann S; Brideau NJ; Lotfy P; Wu X; Novick SJ; Strutzenberg T; Griffin PR; Hsu PD; Lyumkis D
Cell; 2018 Sep; 175(1):212-223.e17. PubMed ID: 30241607
[TBL] [Abstract][Full Text] [Related]
16. Discovery of Diverse CRISPR-Cas Systems and Expansion of the Genome Engineering Toolbox.
Koonin EV; Gootenberg JS; Abudayyeh OO
Biochemistry; 2023 Dec; 62(24):3465-3487. PubMed ID: 37192099
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas guides the future of genetic engineering.
Knott GJ; Doudna JA
Science; 2018 Aug; 361(6405):866-869. PubMed ID: 30166482
[TBL] [Abstract][Full Text] [Related]
18. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system.
Zetsche B; Gootenberg JS; Abudayyeh OO; Slaymaker IM; Makarova KS; Essletzbichler P; Volz SE; Joung J; van der Oost J; Regev A; Koonin EV; Zhang F
Cell; 2015 Oct; 163(3):759-71. PubMed ID: 26422227
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Based Technologies: Impact of RNA-Targeting Systems.
Terns MP
Mol Cell; 2018 Nov; 72(3):404-412. PubMed ID: 30388409
[TBL] [Abstract][Full Text] [Related]
20. RNA editing with CRISPR-Cas13.
Cox DBT; Gootenberg JS; Abudayyeh OO; Franklin B; Kellner MJ; Joung J; Zhang F
Science; 2017 Nov; 358(6366):1019-1027. PubMed ID: 29070703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
